Topics on vitamin D in systemic lupus erythematosus: analysis of evidence and critical literature review

Immunologic Research

Volumn 65, Issue 2, 2017, Pages 495-511

  Marinho, António ^a,b   Taveira, Mariana ^c   Vasconcelos, Carlos ^a,b  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^c Serviço de Medicina Interna   (Portugal)

Author keywords

Antigen presenting cells; Epigenome; Inflammation; Lupus; Major histocompatibility complex genes; Randomized controlled trials; Regulatory T cells; T helper 17 cells; Transcriptome; Vitamin D; Vitamin D receptor single nucleotide polymorphisms; Vitamin D response elements

Indexed keywords

CALCITRIOL; TRANSCRIPTOME; UNTRANSLATED RNA; VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; HLA ANTIGEN;

ANTIGEN PRESENTING CELL; ARTICLE; ATHEROSCLEROSIS; BINDING SITE; DISEASE PREDISPOSITION; EPIGENETICS; GENETIC VARIATION; HUMAN; IMMUNOMODULATION; INFLAMMATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REGULATORY T LYMPHOCYTE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TH17 CELL; TRANSCRIPTION REGULATION; TRANSCRIPTOMICS; VITAMIN D DEFICIENCY; ANTIGEN PRESENTATION; EVIDENCE BASED MEDICINE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIGEN PRESENTATION; EPIGENESIS, GENETIC; EVIDENCE-BASED MEDICINE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HLA ANTIGENS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, CALCITRIOL; T-LYMPHOCYTES, REGULATORY; TH17 CELLS; TRANSCRIPTOME; VITAMIN D;

EID: 85013392522     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-017-8903-5     Document Type: Article

References (63)

1. Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol. 2012;24(6):651–7.
2. Askanase A, Shum K, Mitnick H. Systemic lupus erythematosus: an overview. Soc Work Health Care. 2012;51(7):576–86.
3. Kunz M. Lupus erythematosus. Part I: epidemiology, genetics and immunology. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG. 2013;11(8):709–19.
4. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.
5. Perricone C, Agmon-Levin N, Colafrancesco S, Shoenfeld Y. Vitamins and systemic lupus erythematosus: to D or not to D. Expert Rev Clin Immunol. 2013;9(5):397–9.
6. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482–96.
7. Ben-Zvi I, Aranow C, Mackay M, Stanevsky A, Kamen DL, Marinescu LM, et al. The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One. 2010;5(2):e9193.
8. Borella E, Nesher G, Israeli E, Shoenfeld Y. Vitamin D: a new anti-infective agent? Ann N Y Acad Sci. 2014;1317:76–83.
9. Bizzaro G, Shoenfeld Y. Vitamin D: a panacea for autoimmune diseases? Can J Physiol Pharmacol. 2015;93(5):395–7.
10. Ruiz-Irastorza G, Gordo S, Olivares N, Egurbide MV, Aguirre C. Changes in vitamin D levels in patients with systemic lupus erythematosus: effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken). 2010;62(8):1160–5.
11. Kamen DL. Vitamin D in lupus - new kid on the block? Bull NYU Hosp Joint Dis. 2010;68(3):218–22.
12. Vinh Quoc Luong K, Nguyen LT. The beneficial role of vitamin D in systemic lupus erythematosus (SLE). Clin Rheumatol. 2012;31(10):1423–35.
13. Cocco E, Meloni A, Murru MR, Corongiu D, Tranquilli S, Fadda E, et al. Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles. PLoS One. 2012;7(7):e41678.
14. Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009;5(2).
15. Binkley N, Ramamurthy R, Krueger D, et al. Endocrinol Metab Clin North Am Endocrinol Metab Clin North Am. 2010;39(2):287. contents
16. Bettencourt A, Carvalho C, Leal B, Brás S, Lopes D Martins da Silva A et al. The protective role of HLA-DRB1 (∗) 13 in autoimmune diseases. J Immunol Res. 2015;2015.
17. Xiong J, He Z, Zeng X, Zhang Y, Hu Z. Association of vitamin D receptor gene polymorphisms with systemic lupus erythematosus: a meta-analysis. Clin Exp Rheumatol. 2014;32(2):174–81.
18. Mao S, Huang S. Association between vitamin D receptor gene BsmI, FokI, ApaI and TaqI polymorphisms and the risk of systemic lupus erythematosus: a meta-analysis. Rheumatol Int. 2014;34(3):381–8. doi:10.1007/s00296-013-2898-6.
19. Holick MF. Vitamin D: extraskeletal health. Rheum Dis Clin N Am. 2012;38(1):141–60.
20. Kemp MG, Lindsey-Boltz LA, Sancar A. UV light potentiates STING (stimulator of interferon genes)-dependent innate immune signaling through deregulation of ULK1 (Unc51-like kinase 1). J Biol Chem. 2015;290(19):12184–94.
21. Antico A, Tampoia M, Tozzoli R, Bizzaro N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun Rev. 2012;12:127–36.
22. Kang SW, Kim SH, Lee N, Lee WW, Hwang KA, Shin MS, et al. 1,25-Dihyroxyvitamin D3 promotes FOXP3 expression via binding to vitamin D response elements in its conserved noncoding sequence region. J Immunol. 2012;188(11):5276–82.
23. Lerman MA, Burnham J, Behrens E. 1, 25 Dihydroxyvitamin D3 limits monocyte maturation in lupus sera. Lupus. 2011;20(7):749–53.
24. Wu HJ, Lo Y, Luk D, Lau CS, Lu L, Mok MY. Alternatively activated dendritic cells derived from systemic lupus erythematosus patients have tolerogenic phenotype and function. Clin Immunol. 2015;156(1):43–57.
25. Aranow C, Kamen DL, Dall'Era M, Massarotti EM, Mackay MC, Koumpouras F, et al. Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheumatol. 2015;67(7):1848–57.
26. Terrier B, Derian N, Schoindre Y, Chaara W, Geri G, Zahr N, et al. Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther. 2012;14:R221.
27. Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015;45(2):344–55.
28. Souza VA, Bastos MG, Fernandes NMS, Mansur HN, Raposo NRB, Souza DNK, et al. Association of hypovitaminosis D with systemic lupus erythematosus and inflammation. Jornal Brasileiro Nefrologia. 2014;36(4):430–6.
29. Banica LM, Besliu AN, Pistol GC, Stavaru C, Vlad V, Predeteanu D et al. Dysregulation of anergy-related factors involved in regulatory T cells defects in systemic lupus erythematosus patients: rapamycin and vitamin D efficacy in restoring regulatory T cells. Int J Rheum Dis. 2014 28.
30. Piantoni S, Andreoli L, Scarsi M, Zanola A, Dall'Ara F, Pizzorni C, et al. Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D. Lupus. 2015;24(4–5):490–8.
31. Wahono CS, Rusmini H, Soelistyoningsih D, Hakim R, Handono K, Endharti AT, et al. Effects of 1,25(OH)2D3 in immune response regulation of systemic lupus erithematosus (SLE) patient with hypovitamin D. Int J Clin Exp Med. 2014;7(1):22–31.
32. Drozdenko G, Heine G, Worm M. Oral vitamin D increases the frequencies of CD38+ human B cells and ameliorates IL-17-producing T cells. Exp Dermatol. 2014;23(2):107–12.
33. Marinho A, Carvalho C, Boleixa D, Bettencourt A, Leal B, Guimarães J et al. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3+/IL-17A ratio and clinical course in systemic lupus erythematosus patients: a study in a Portuguese cohort. Immunol Res. 2016 16.
34. Vukić M, Neme A, Seuter S, Saksa N, de Mello VD, Nurmi T, et al. Relevance of vitamin D receptor target genes for monitoring the vitamin D responsiveness of primary human cells. PLoS One. 2015;13:10(4).
35. Adnan N, Kiani, Fang H, Magder LS, Petri M. Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford). 2013;52(11):2071–6.
36. Robinson AB, Tangpricha V, Yow E, Gurion R, Schanberg LA, McComsey GA, for the APPLE investigators. Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: An Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy. Lupus Science & Medicine 2014; 1.
37. Robinson AB, Tangpricha V, Yow E, Gurion R, McComsey GA, Schanberg LE; APPLE Investigators. Vitamin D deficiency is common and associated with increased C-reactive protein in children and young adults with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus substudy. Lupus Sci Med. 2014; 1 (1).
38. Lertratanakul A, et al. 25-Hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. Arthritis Care Res (Hoboken). 2014;66(8):1167–76.
39. Reynolds JA, Haque S, Berry JL, Pemberton P, Teh LA, Ho P, et al. 25-hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2012;51(3):544–51.
40. Sabio JM, Vargas-Hitos JA, Martinez-Bordonado J, Navarrete-Navarrete N, Díaz-Chamorro A, Olvera-Porcel C, et al. Association between low 25-hydroxyvitamin D, insulin resistance and arterial stiffness in nondiabetic women with systemic lupus erythematosus. Lupus. 2015;24(2):155–63.
41. Reynolds JA, Haque S, Williamson K, Ray DW, Alexander MY, Bruce IN. Vitamin D improves endothelial dysfunction and restores myeloid angiogenic cell function via reduced CXCL-10 expression in systemic lupus erythematosus. Sci Rep. 2016;6:22341.
42. Abou-Raya A, Abou-Raya S, Helmii M. The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial. J Rheumatol. 2013;40(3):265–72.
43. Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, et al. Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev. 2015;14(10):952–69.
44. Irfete S. Fetahu, Hobaus J., Kallay E. Vitamin D and the epigenome. Frontiers in phisiology.2014; 5:164.
45. Kostner K, Denzer N, Muller CS, Klein R, Tilgen W, Reichrath J. The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature. Anticancer Res. 2009;29(9):3511–36.
46. Carlberg C. Genome-wide (over)view on the actions of vitamin D. Front Physiol. 2014;5:167.
47. Rolf L, Damoiseaux J, Hupperts R, Huitinga I, Smolders J.Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules. Autoimmun Rev. 2016.
48. Tuoresmäki P, Väisänen S, Neme A, Heikkinen S, Carlberg C. Patterns of genome-wide VDR locations. PLoS One. 2014 30; 9(4).
49. Arash HN, Spira A, Holick MF. Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. PLoS One. 2013;8(3):e58725.
50. Long MD, Sucheston-Campbell LE, Campbell MJ. Vitamin D receptor and RXR in the post-genomic era. J Cell Physiol. 2015;230(4):758–66.
51. Moray J, Campbell. Vitamin D and the RNA transcriptome: more than mRNA regulation. Front Physiol. 2014;5:181.
52. Carvalho C, Marinho A, Leal B, Bettencourt A, Boleixa D, Almeida I, et al. Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus. 2015;24(8):846–53.
53. Barry EL, Rees JR, Peacock JL, Mott LA, Amos CI, Bostick RM, et al. Genetic variants in CYP2R1, CYP24A1, and VDR modify the efficacy of vitamin D3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J Clin Endocrinol Metab. 2014;99(10):E2133–7.
54. Monticielo OA, Brenol JC, Chies JA, Longo MG, Rucatti GG, Scalco R, Xavier RM. The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus. Lupus. 2012;21(1):43–52.
55. Watad A, Neumann SG, Soriano A, Amital H, Shoenfeld Y. Vitamin D and systemic lupus erythematosus: myth or reality? Isr Med Assoc J. 2016;18(3–4):177–82.
56. Azrielant S, Shoenfeld Y. Eppur Si Muove: vitamin D is essential in preventing and modulating SLE. Lupus. 2016;25(6):563–72.
57. Birmingham DJ, Hebert LA, Song H, Noonan WT, Rovin BH, Nagaraja HN, Yu CY. Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus. 2012;21(8):10.
58. Schoindreet Y al. Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up. Lupus Sci Med. 2014; 1(1).
59. Roy S, Shrinivas K, Bagchi B. A stochastic chemical dynamic approach to correlate autoimmunity and optimal vitamin D range. PLoS One. 2014 Jun27:9(6).
60. Fattizzo B, Zaninoni A, Giannotta JA, Binda F, Cortelezzi A, Barcellini W. Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review. Autoimmun Rev. 2016;15(7):770–5.
61. Agmon-Levin N, Kivity S, Tzioufas AG, López Hoyos M, Rozman B, Efes I, et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome. J Autoimmun. 2012;39(3):234–9.
62. Muscogiuri G, Tirabassi G, Bizzaro G, Orio F, Paschou SA, Vryonidou A, et al. Vitamin D and thyroid disease: to D or not to D? Eur J Clin Nutr. 2015;69(3):291–6.
63. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality - a review of recent evidence. Autoimmun Rev. 2013;12(10):976–89.